Skip to main content

Table 1 Patient’s characteristics, therapies and clinical outcome

From: Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy – potential markers for predicting breast cancer recurrence?

Age (years) N %
 40–49 8 23
 50–59 11 32
 60–69 11 31
  >  70 5 14
Chemotherapy
 Yes 8 23
 No 27 77
Hormone therapy
 Start before RT 12 34
 Start after RT 22 63
 No 1 3
Tumor size (cm)
  <  1 12 34
 1–2 20 57
  >  2 3 9
pTNM
 T1 (a-c) 30 86
 T2 5 14
 N0 30 86
 N1 5 14
 M0 35 100
G1 7 20
G2 26 74
G3 2 6
Hormone receptor status
 Estrogen receptor+ 35 100
 Progesteron receptor+ 35 100
Total dose (Gy)
 40 3 9
 60 27 77
 66 5 14
Total dose of boost (Gy)
 10 25 72
 16 5 14
Clinical outcome
Disease-free
>  3 years
14 40
Disease-free
>  5 years
18 52
Endometrial cancer 1 3
Recurrence/metastases 2 6